tbuckley/cabot-search huggingface dataset:
Molecular Response Analysis By High Throughput Sequencing in Higher Risk Myelodysplastic Syndrome (HR-MDS) Treated Intensively with CPX-351
Authors: Yannick Le Bris, Simon Bouzy, Audrey Ménard, Pascal Turlure, Patrice Chevallier, Marie-Pierre Gourin, Pierre-Yves Dumas, Sylvain Thepot, Anna Berceanu, Sophie Park, Marie-Anne Hospital, Thomas Cluzeau, Jose-Miguel Torregrosa Diaz, Louis Devron, Rosa Sapena, Fatiha Chermat, Sophie Dimicoli Salazar, Marie C Béné, Pierre Fenaux, Pierre Peterlin
Journal: Blood (2022)
Human NGFR+/VCAM-1+/Mcam+ Bone Marrow-Derived Stromal Cells (NVML) Provide Enhanced Support for Normal Hematopoiesis and Are Disrupted in Myelodysplastic Syndrome
Authors: Yuko Kawano, Hiroki Kawano, Daniel K. Byun, Dalia Ghoneim, Thomas J Fountaine, Mark W. LaMere, John M. Ashton, Mitra Azadniv, Jane L. Liesveld, Youmna Kfoury, David T. Scadden, Michael W. Becker, Laura M. Calvi
Journal: Blood (2022)
The Combination of Decitabine Plus Venetoclax Is an Active Salvage Therapy for AML Post HR-MDS Progressed during Treatment with Azacitidine Based Regimens
Authors: Angela Consagra, Alessandro Sanna, Marco Gabriele Raddi, Luca Rigodanza, Enrico Attardi, Cristina Amato, Margherita Cassari, Elena Tofacchi, Giorgio Mattiuz, Sven de Pourcq, Valeria Santini
Journal: Blood (2022)
Effectiveness of an Antifungal Stewardship Program in a Hematology Ward at a Madrid Teaching Hospital: The Time Is Now
Authors: Maria Arguello, Lucía Castilla García, Marta Callejas, Patricia Garcia Ramirez, Jose María Aspa Cilleruelo, Paula Gili Herreros, Celia Martínez Vázquez, Gumán López de Hontanar Torres, Pedro Antonio Rodriguez Barquero, Galina Motornaya, Gema Baldominos Utrilla, Julio Garcia Suarez
Journal: Blood (2022)
EMT-like Activation in CLL Provides Novel Therapeutic Target
Authors: Charlott Repschlaeger, Mariette Odabashian, Filomena Spada, Zamzam Almutairi, John G. Gribben, Francesco Forconi, Emre Sayan, Alexessander Couto Alves, Charline Giroud, Oleg Fedorov, Marina Kriajevskaia, Sergey Krysov
Journal: Blood (2022)
Low-Dose Antithymocyte Globulin Plus Low-Dose Post-Transplant Cyclophosphamide for Prevention of Graft-Versus-Host Disease after Haploidentical Peripheral Blood Stem Cell Transplants: A Large Sample, Long-Term Follow-up Retrospective Study
Authors: Xingying Li, Jun Yang, Liping Wan, Yu CAI, Kun Zhou, Chongmei Huang, Yin Tong, Huiying Qiu, Xianmin Song
Journal: Blood (2022)
Treatment Patterns and Outcomes of Patients with Primary or Secondary Acute Myeloid Leukemia By Type of Site (Academic or Community/Government): A CONNECT® Myeloid Registry Study
Authors: Bart L. Scott, Michael R. Savona, Gail J. Roboz, Karen Seiter, Daniel A. Pollyea, Irene S. DeGutis, Pavel Kiselev, Edward Yu, Ali McBride, Willem Heydendael, Harry P. Erba
Journal: Blood (2022)
Allogeneic Transplant As a Curative Option for Relapsed/Refractory Large B-Cell Lymphoma in the Era of CAR T-Cell Therapy: A Monocentric Retrospective Study
Authors: Pauline Roché, Gabriel Brisou, Sabine Furst, Robin Noel, Catalina Montes De Oca, Aude Collignon, Luca Inchiappa, Jean Marc Schiano De Colella, Isabelle Brenot Rossi, Thibaut Reichert, Sophie Thévenet, Bechara Mfarrej, Boris Calmels, Didier Blaise, Christian Chabannon, Raynier Devillier
Journal: Blood (2022)
Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) +/- Daratumumab Treatment Results in Sustained Hematologic Response in Patients with AL Amyloidosis: A Retrospective Analysis of Patients at Mayo Clinic
Authors: Yael Kusne, Rodrigo Fonseca, Mariano Arribas, Molly Klanderman, Julia E. Wiedmeier, Craig B. Reeder, Jeremy T. Larsen, P. Leif Bergsagel, Julie L Rosenthal, Rafael Fonseca
Journal: Blood (2022)
Evaluate Dynamics of IL-6 Release during Step-up Dosing of Subcutaneous Administration of Odronextamab Via a Quantitative Systems Pharmacology Modeling Approach
Authors: Masood Khaksar Toroghi, Min Zhu, Srikanth R. Ambati, Hesham Mohamed, Aafia Chaudhry, Hong Yan, John D. Davis, A. Thomas DiCioccio
Journal: Blood (2022)
Genome-Wide Association Study Identifies Variants Associated with Clinical Outcomes in Pediatric Patients with Newly Diagnosed Acute Myeloid Leukemia
Authors: Richard J Marrero, Xueyuan Cao, Huiyun Wu, Hiroto Inaba, Susana C. Raimondi, Ching-Hon Pui, Raul C. Ribeiro, Jeffrey E. Rubnitz, Stanley B. Pounds, Jatinder K. Lamba
Journal: Blood (2022)
Efficacy of Azacitidine Post-Transplant Maintenance for FLT3-Negative Acute Myeloid Leukemia and Myelodysplastic Syndrome
Authors: Oren Pasvolsky, Rima M. Saliba, Uday R Popat, Amin M Alousi, Rohtesh S. Mehta, Jason Yeh, Gheath Alatrash, Adeel Masood, Jeremy L. Ramdial, Gabriela Rondon, Partow Kebriaei, Richard E Champlin, Elizabeth J Shpall, Betul Oran
Journal: Blood (2022)
Analysis of the Platelet Proteome Reveals Insights into the Pro-Inflammatory and Pro-Thrombotic State Associated with the Philadelphia Chromosome-Negative Myeloproliferative Neoplasms
Authors: Sarah Kelliher, Fionnuala Ní Áinle, Luisa Weiss, Sara Gamba, Ella Fouhy, Marina Marchetti, Francesca Schieppati, Hayley Macleod, Kathleen Bennett, Anne Fortune, Su Wai Maung, Michael Fay, Mary Frances McMullin, Stuart Macleod, Claire Andrews, Liam Smyth, Karen Murphy, Eibhlin Conneally, Patricia Maguire, Anna Falanga, Barry Kevane
Journal: Blood (2022)
Patients Experience with Telemedicine during COVID-19 Pandemic in a Tertiary Cancer Center in Qatar
Authors: Israa Elhakeem, Phool Iqbal, Abdulqadir Jeprel Nashwan, Muhammad Abubakar, Arslan Tahir Jawad, Mousa A AlHiyari, Prem Chandra, Maab Abdelrahman Osman, Sara Saeed Mohamed, Mohammed N Alkhatib, Mohamed A Yassin
Journal: Blood (2022)
Molecular Patterns Identify Distinct Subclasses of Myeloid Neoplasia
Authors: Tariq Kewan, Arda Durmaz, Waled Bahaj, Carmelo Gurnari, Hussein Awada, Olisaemeka Ogbue, Ramsha Ahmed, Simona Pagliuca, Hassan Awada, Yasuo Kubota, Minako Mori, BEN Ponvilawan, Bayan Al-Share, Bhumika J. Patel, Hetty E. Carraway, Jacob Scott, Suresh Kumar Balasubramanian, Taha Bat, Yazan F. Madanat, Mikkael A. Sekeres, Torsten Haferlach, Valeria Visconte, Jaroslaw P. Maciejewski
Journal: Blood (2022)
Ruxolitinib for Myelofibrosis in Resource Limited Settings : A Slip between the Cup and the Lip
Authors: Karthika K V, Neeraj Sidharthan, Anjana K V, Remya Sudevan, Ullas Mony, Renjitha Bhaskaran, Manoj Unni, Rema Ganapathy, Nikhil Krishna Haridas
Journal: Blood (2022)
Mechanisms of Polycomb Group Protein-Mediated Fetal Hemoglobin Silencing
Authors: Kunhua Qin, Peng Huang, Xianjiang Lan, Megan S. Saari, Eugene Khandros, Osheiza Y. Abdulmalik, Cheryl A. Keller, Belinda M. Giardine, Ross C. Hardison, Junwei Shi, Gerd A. Blobel
Journal: Blood (2022)
Targeting Iron Homeostasis As a Therapeutic Strategy in Multiple Myeloma
Authors: Sara ovejero-Merino, Julie Devin, Tatiana Cañeque, Laura Alibert, Guilhem Requirand, Nicolas Robert, Alizée Steer, Amelie Machura, Christophe Hirtz, Angélique Bruyer, Laure Vincent, Guillaume Cartron, Charles Herbaux, Raphael Rodriguez, Caroline Bret, Jerome Moreaux
Journal: Blood (2022)
Gilteritinib Activity in Refractory or Relapsed <i>FLT3</i>-Mutated Acute Myeloid Leukemia Patients Previously Treated By Intensive Chemotherapy and Midostaurin: A Study from the French AML Intergroup ALFA/Filo
Authors: Pierre-Yves Dumas, Emmanuel Raffoux, Emilie Berard, Sarah Bertoli, Marie Anne Hospital, Mael Heiblig, Yohan Desbrosses, Caroline Bonmati, Cecile Pautas, Juliette Lambert, Corentin Orvain, Anne Banos, Florence Pasquier, Pierre Peterlin, Tony Marchand, Madalina Uzunov, Jamilé Frayfer, Pascal Turlure, Thomas Cluzeau, Eric Jourdan, Chantal Himberlin, Emmanuelle Tavernier, Alban Villate, Stéphanie Haiat, Marie-Lorraine Chretien, Martin Carre, Sylvain Chantepie, Iona Vaida, Mathieu Wemeau, Safia Chebrek, Gaëlle Guillerm, Romain Guieze, Houria Debarri, Eve Gehlkopf, Kamel Laribi, Ambroise Marçais, Alberto Santagostino, Marie C Bene, Ariane C Mineur, Arnaud Pigneux, Herve Dombret, Christian Recher
Journal: Blood (2022)
Outcomes with Eltrombopag for Poor Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis
Authors: Moazzam Shahzad, Qamar Iqbal, Farrukh Munir, Sakina Abbas, Maheen Zaidi, Nimra Shafi, Muhammad Sohaib, Waleed Ahmed Mir, Iqra Anwar, Sibgha Gull Chaudhary, Maggie Nelson, Philip Lubanski, Zahra Mahmoudjafari, Peiman Hematti, Sunil H Abhyankar, Joseph P. McGuirk, Muhammad Umair Mushtaq
Journal: Blood (2022)
Development of an Off-the-Shelf Chimeric Antigen Receptor (CAR)-T Cell Therapy for T-Cell Acute Lymphoblastic Leukemia (T-ALL) without Gene Editing
Authors: Xing Fah Alex Wong, Josie Ng, Simin Zheng, Rizal Ismail, Hongliang Qian, Dario Campana, Ying Xim Tan
Journal: Blood (2022)
Survival of Patients with Primary Mediastinal B-Cell Lymphoma Treated By Immunochemotherapy with or without Radiotherapy
Authors: Kamila Polgarova, Andrea Janíková, David Belada, Vit Prochazka, Juraj Ďuraš, Heidi Móciková, Kateřina Steinerová, Vít Campr, Petra Blahovcová, David Zogala, Václav Ptáčník, Marek Trneny
Journal: Blood (2022)
Clinical and Molecular Response Assessment of AML Harboring Non-Canonical <i>FLT3</i> p.N676K Driver Mutations to FLT3 Inhibitor Therapies
Authors: Gregory W. Roloff, Andrew S. Artz, Wendy Stock, Olatoyosi Odenike, Emily Dworkin, Geoffrey D. Wool, Carrie Fitzpatrick, Jeremy Segal, Peng Wang, Michael W. Drazer
Journal: Blood (2022)
Novel Autochthonous Mouse Models of Serve As Preclinical Tools to Investigate Pathogenesis and Treatment of MCD/C5 DLBCL
Authors: Ruth Flümann, Julia Hansen, Benedikt Pelzer, Ilmars Kisis, Tim Lohmann, Thorsten Persigehl, Nima Abedpour, Martin Peifer, Reinhard Buettner, Bastian von Tresckow, Ron Jachimowicz, Hans Christian Reinhardt, Gero Knittel
Journal: Blood (2022)
Results from the Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-946 in Healthy Volunteers
Authors: Xiaoshu Dai Gurov, Elizabeth Merica, Varsha Iyer, Annie Claeys, Spurthi Patil, Rolandas Urbstonaitis, James Xiao, Michael U. Callaghan
Journal: Blood (2022)
Intensive Pegcetacoplan Dosing in the Management of Acute Hemolysis As Part of the 307 Open-Label Extension Study
Authors: Morag Griffin, Richard Kelly, Dries Deeren, Yeow Tee Goh, Eric Tse, Kensuke Usuki, Raymond Wong, Regina Horneff, Lisa Tan, Michael Yeh, Jessica Savage, Jeff Szer
Journal: Blood (2022)
Acute Lymphoblastic Leukemia in Patients 60 Years and Older Treated with Pediatric-Inspired Protocols, 20 Years of Follow-up
Authors: Maria Agustina Perusini, Eshetu G. Atenafu, Aniket Bankar, Vikas Gupta, Mark D. Minden, Jad Sibai, Dawn Maze, Marta B. Davidson, Steven M. Chan, Fernando Binder, Guillaume Richard-Carpentier, Salman Alharbi, Claire Andrews, Karen Yee, Andre C. Schuh, Hassan Sibai
Journal: Blood (2022)
The Exportin, XPO2, Is a Novel Therapeutic Target in Pediatric, Adolescent and Young Adult AML
Authors: Grace Egan, Rose Hurren, Chaitra Sarathy, Geethu Emily Thomas, Dilshad H. Khan, Yongran Yan, Yue Feng, Brandon Brown, Steven M. Kornblau, Aaron D. Schimmer
Journal: Blood (2022)
Optimizing the Supportive Care of Intensive Chemotherapy in AML : Impact of Vitamin C and D Supplementation in Patients with <i>NPM1</i> Mutation. a Dataml Registry Study
Authors: Pierre Luc Mouchel, Sarah Bertoli, Emilie Berard, Francois Vergez, Jean-Baptiste Rieu, Isabelle Luquet, Laetitia Largeaud, Nathan Guiraud, Jean-Emmanuel Sarry, Audrey Sarry, Francoise Huguet, Suzanne Tavitian, Christian Recher
Journal: Blood (2022)
<i>Evaluation of Unrestricted Somatic Stem Cells Therapy in an Ex-Vivo and in-Vivo Acquired Severe Aplastic Anemia Model</i>
Authors: Edo Schaefer, Yanling Liao, Morgan Anderson-Crannage, Bruno Hochberg, Hanif Mouehla, Jian Pan, Bernadette Fallon, Janet Ayello, Mitchell S. Cairo
Journal: Blood (2022)
Effect of Daratumumab on Stem Cell Mobilization and Engraftment Kinetics Post Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma
Authors: Samir Oza, Ronit Slotky, Pranay Vissa, Pooja Phull, Sukhdeep Kaur, Hyung C. Suh, Michele L. Donato, Scott D. Rowley, Noa Biran, David H. Vesole, David Siegel, Harsh Parmar
Journal: Blood (2022)
The Prognostic Impact of <i>HMGCLL1</i> Gene Variant on Treatment Outcomes in Chronic Myeloid Leukemia (CML) Patients: Adverse Impact on the Response, Failure, and Progression with Imatinib Which Can be Abrogated By the Use of 2nd Generation Tyrosine Kinase Inhibitor (TKI) Upfront Therapy
Authors: Maria Agustina Perusini, Taehyung Simon Kim, Daniela Žácková, Katia B Pagnano, Jiří Mayer, Carolina Pavlovsky, Ivana Ježíšková, Anežka Kvetková, Tomáš Jurček, Beatriz Moiraghi, Ana Ines Varela, Michele Bianchini, Ana Beatriz Pascoal Lopes, Gislaine B O Duarte, Young Seok Yoo, Carmino Antonio Souza, Jessie Medeiros, Hye Won Lee, Kyoung Ha Kim, Seong Yoon Yi, Myung Hee Chang, Sagi Abelson, Dennis Dong Hwan Kim
Journal: Blood (2022)
An Updated Analysis on Safety and Efficacy of Avapritinib in Patients with Advanced Systemic Mastocytosis from the Explorer Clinical Study: Long-Term Efficacy and Safety
Authors: Daniel J. DeAngelo, Deepti H. Radia, Tracy I. George, William A. Robinson, Albert T. Quiery, Mark W. Drummond, Prithviraj Bose, Elizabeth O. Hexner, Elliott Winton, Hans-Peter Horny, Meera Tugnait, Hui-Min Lin, Saša Dimitrijević, Javier I. Munoz-Gonzalez, Ilda Bidollari, Michael W. Deininger, Jason Gotlib
Journal: Blood (2022)
Outcomes in Pregnant HbSS and HbSβ0-Thalassemia Sickle Cell Disease Patients Receiving Scheduled Exchange Transfusions: A Retrospective Study
Authors: Anil Ananthaneni, Taras Benzar, Vishwa Grant, Kenna Leethy, Jacqueline Walton, Samip R Master, Richard Preston Mansour, Poornima Ramadas
Journal: Blood (2022)
Patient-Reported Outcomes from a Phase 2, Randomized Trial Evaluating the Safety and Efficacy of Pozelimab and Cemdisiran in Patients with Paroxysmal Nocturnal Hemoglobinuria
Authors: Chris Hartford, Bradley Dain, Steven Sherman, Yi Zhang, Rodrigo Pavani, Lisa Aurand, Diana Rofail, Richard Kelly
Journal: Blood (2022)
Biomarker-Driven Treatment Strategy in High-Risk Large B-Cell Lymphoma: Final Results of a Nordic Phase 2 Study
Authors: Sirpa Leppa, Judit M. Jørgensen, Marja-Liisa Karjalainen-Lindsberg, Klaus Beiske, Mette Pedersen, Kristina Drott, Annika Pasanen, Kristiina Karihtala, Susanna Mannisto, Leo Meriranta, Bente Wold, Marianne Brodtkorb, Unn Merete Fagerli, Thomas S. Larsen, Lars Munksgaard, Kaisa Sunela, Øystein Fluge, Sirkku Jyrkkio, Peter de Nully Brown, Harald Holte
Journal: Blood (2022)
Prophylactic Donor Lymphocyte Infusion in Patients after Allogeneic Stem Cell Transplantation with Post-Transplant Cyclophosphamide Is Associated with Low Relapse Risk and Excellent Survival in Patients below 65 Years with Acute Myeloid Leukemia and High-Risk Myelodysplasia
Authors: Peter A. Von Dem Borne, Tjeerd J.F. Snijders, Danielle van Lammeren, Janneke Tijmensen, Erwin V. Planken, Henriette Levenga, Yascha van den Berg, Erik WAF Marijt, Peter van Balen, Jennifer M. Tjon, Joost S.P. Vermaat, Theo L. Nering Bögel, Mirjam A. Oudshoorn, Constantijn J.M. Halkes, Hendrik Veelken
Journal: Blood (2022)
Evaluating Stem Cells to Predict Post-Transplant Relapse in the Myelodysplastic Syndromes
Authors: Benjamin Kroger, Yi Huang, Prapti Patel, Aimaz Afrough, Gurbakhash Kaur, Larry D. Anderson, Farrukh T. Awan, Praveen Ramakrishnan, Kunal Verma, Russell Vittrup, Robert H. Collins, Madhuri Vusirikala, Yazan F. Madanat, Roni Tamari, Stephen S. Chung
Journal: Blood (2022)
Nelarabine Combination Therapy for Relapsed or Refractory T-Cell Acute Lymphoblastic Lymphoma/Leukemia
Authors: Shai Shimony, Yiwen Liu, Yannis K. Valtis, Jonathan D. Paolino, Andrew E. Place, Andrew M. Brunner, Lachelle D. Weeks, Lewis B. Silverman, Lynda M. Vrooman, Donna S. Neuberg, Richard M. Stone, Daniel J. DeAngelo, Marlise R. Luskin
Journal: Blood (2022)
Molecular Characterization of Response/Loss-of-Response to Ruxolitinib in Patients with Myelofibrosis
Authors: Paola Guglielmelli, Fiorenza Irushani Vanderwert, Simone Romagnoli, Giacomo Coltro, Giuseppe Gaetano Loscocco, Francesco Mannelli, Laura Calabresi, Giulia Gentili, Giada Rotunno, Niccolò Bartalucci, Valentina Boldrini, Emanuela Sant'Antonio, Danilo Tarantino, Marco Pieraccioli, Alessandro Vannucchi
Journal: Blood (2022)
Subcutaneous Epcoritamab with Rituximab + Lenalidomide in Patients with Relapsed or Refractory Follicular Lymphoma:Phase 1/2 Trial Update
Authors: Lorenzo Falchi, Pau Abrisqueta, Marcel Nijland, Sirpa Leppä, Martin Hutchings, Harald Holte, Reid W Merryman, Pieternella Lugtenburg, Sven de Vos, Chan Y. Cheah, Jacob Haaber Christensen, Luca Arcaini, Kristina Drott, Mats Hellström, Lori A. Leslie, Umberto Vitolo, Ali Rana, Aqeel Abbas, Liwei Wang, Minh Dinh, David Belada
Journal: Blood (2022)
Dysfunctional Clusterin-Positive Hematopoietic Stem Cells Expand with Aging
Authors: Shuhei Koide, Motohiko Oshima, Akira Nishiyama, Koichi Murakami, Naoki Itokawa, Yaeko Nakajima-Takagi, Zhiqian Zheng, Nozomi Yusa, Kazuaki Yokoyama, Arinobu Tojo, Tomohiko Tamura, Atsushi Iwama
Journal: Blood (2022)
Identification of Phenotypic Subgroups of Acute Myeloid Leukemia, Defined By Differentiation According to Who 2022 Classification
Authors: Wolfgang Kern, Prashant R. Tembhare, Reza Nejati, Fatima Zahra Jelloul, Wencke Walter, Joseph D. Khoury, Torsten Haferlach
Journal: Blood (2022)
T-Cell Senescence and Exhaustion Are Associated with Interval Progression of Multiple Myeloma before Autologous Hematopoietic Cell Transplant
Authors: Alicia Bao, Ruchi Kudalkar, Jose Rodriguez, Qiuhong Zhao, Nidhi Sharma, Naresh Bumma, Srinivas Devarakonda, Abdullah Khan, Ashley E. Rosko, Elvira Umyarova, Don M. Benson, Francesca Cottini
Journal: Blood (2022)
Hematological Response to Avatrombopag Switch in Thrombopoietin Receptor Agonist-Refractory Aplastic Anemia
Authors: Liping Jing, Yingchang Mi, Huihui Fan, Wenrui Yang, Yuan Li, Jianping Li, Li Zhang, Xin Zhao, Kang Zhou, Lei Ye, Fengkui Zhang
Journal: Blood (2022)
Clinical Validation of Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of B Neoplasia
Authors: Lucila Kerbauy, Larissa Leggieri Coa, Micheli Severo Sielski, Juliana Aparecida Preto Godoy, Andrea Tiemi Kondo, Julia Teixeira Cottas Azevedo, Augusto Barbosa, Oswaldo Keith Okamoto, Jose Mauro Kutner, Nelson Hamerschlak, Raquel de Melo Alves Paiva
Journal: Blood (2022)
Comparison of Dexamethasone Versus Prednisolone Prephase in Induction Therapy of Pediatric Acute Lymphoblastic Leukemia: A Single-Center, Randomized Controlled Study from India
Authors: Anamika Bakliwal, Jatin Munjal, Rituparna Chetia, Debranjani Chattopadhyay, Sudeep Vaniyath, Ashok K Rajoreya, Uttam Kumar Nath
Journal: Blood (2022)
Association of Clinical Response of ITP Patients to Eltrombopag with the Regulation of Platelet Binding to Lymphocytes
Authors: Silvana Novelli, Carlos Zamora, Silvia Vidal, David Valcarcel, Blanca Sanchez-Gonzalez, Francesc Garcia-Pallarols, Yva Rodriguez, Abel Domingo, Marta Canet Maldonado, Pável E Olivera
Journal: Blood (2022)
Asparagine Bioavailability Regulates the Translation of <i>MYC</i> oncogene in Lymphoid Malignancies
Authors: Sankalp Srivastava, Jie Jiang, Gretchen Seim, Jagannath Misra, Utpal Dave, Reuben Kapur, Jiehao Zhou, Jing Fan, Ronald Wek, Ji Zhang
Journal: Blood (2022)
Predictive Factors of Relapse for Primary Immune Thrombocytopenia in Adults: A Single-Center Retrospective Cohort Analysis
Authors: Xiyan Wang, Xiaofan Liu, Yueshen Ma, Jiao Wang, Rongfeng Fu, Yunfei Chen, Wei Liu, Ting Sun, Mankai Ju, Hui Yuan Li, Feng Xue, Changping Li, Zhen Song, Lei Zhang, Renchi Yang
Journal: Blood (2022)
A Novel Germline <i>PAX5</i> Single Exon Deletion in a Paediatric Patient with B-Cell Leukaemia
Authors: Nienke van Engelen, Merel A. Roest, Freerk van Dijk, Edwin Sonneveld, Reno Bladergroen, Simon van Reijmersdal, Vincent H.J. van der Velden, Patricia G. Hoogeveen, W.A. Kors, Esme Waanders, Roland P. Kuiper, Marjolijn C.J. Jongmans
Journal: Blood (2022)
Clonal Hematopoiesis Detected at the Time of Tyrosine Kinase Inhibitor Cessation Is Associated with Delayed Molecular Recurrence after Treatment-Free Remission in Patients with CML
Authors: Susan Branford, Naranie Shanmuganathan, Carol Wadham, Nur Hezrin Shahrin, Adelina Fernandes, Jinghua Feng, Andreas W Schreiber, Chung Hoow Kok, Verity A Saunders, Rob King, Ming Lin, Ilaria S Pagani, David T Yeung, David M Ross, Agnes S.M. Yong, Timothy Hughes
Journal: Blood (2022)
Efficacy and Safety of Bosutinib Vs Imatinib By Charlson Comorbidity Index in Newly Diagnosed Patients with Chronic Myeloid Leukemia
Authors: Michael W. Deininger, Tim H Brummendorf, Jeffrey H. Lipton, Dragana Milojkovic, Leif Stenke, Eric Leip, Simon Purcell, Andrea Viqueira, Jorge E. Cortes
Journal: Blood (2022)
Leg Ulcer Prevalence and Outcomes in a Real-World, Multicenter, Retrospective Study of Patients Treated with Voxelotor
Authors: Caterina P Minniti, Henny H. Billett, Daniel McMahon, Modupe Idowu, Nirmish Shah, Richard A. Drachtman, Archana Sharma, Alexander Glaros, Maureen Okam Okam Achebe, Alecia C Nero, Susanna Curtis, Biree Andemariam
Journal: Blood (2022)
Extracellular DEK Activates NRF2 Antioxidant Targets and Drives Expansion of Functional and ROS-Low Human Hematopoietic Stem Cells
Authors: James Ropa, Sarah Gutch, Lindsay Beasley, Paola Aguilar Neuville, Scott Cooper, Di Cao, Wouter van't Hof, Maureen Legendre, Mark Kaplan, David M Markovitz, Maegan L. Capitano
Journal: Blood (2022)
Identification of the Proteasome Subunits PSMB4 and PSMD4 As Novel Targets in Multiple Myeloma Patients Carrying 1q21 Amplification
Authors: Jessica Burroughs Garcia, Paola Storti, Nicolas Thomas Iannozzi, Laura Notarfranchi, Denise Toscani, Valentina Marchica, Vincenzo Raimondi, Luca Agnelli, Valentina Franceschi, Giannalisa Todaro, Oxana Lungu, Matia Bernardi, Matteo Scita, Gabriella Sammarelli, Gaetano Donofrio, Anna Benedetta Dalla Palma, Nicola Giuliani
Journal: Blood (2022)
T-Cell Replete Unrelated Cord Blood Transplant Give Superior Outcomes to Other Donor Sources in High Risk and Relapsed/Refractory Paediatric Myeloid Malignancy
Authors: Claire Horgan, Khushnuma Mullanfiroze, Archana Rauthan, Katharine Patrick, Naeem Akram Butt, Oana Mirci-Danicar, Olya O'Connor, Caroline Furness, Akshay Deshpande, Sarah Lawson, Valerie Broderick, Pamela Evans, Brenda Gibson, Wing Roberts, Sevasti Galani, Amy A. Kirkwood, Beki James, Kanchan Rao, Persis J. Amrolia, Robert F. Wynn
Journal: Blood (2022)
Double-Blind, Placebo Controlled, Randomized, Multicenter, Phase II Study to Assess the Efficacy of the High Affinity CXCR4 Inhibitor BL-8040 As Addition to Consolidation Therapy in AML By the SAL and OSHO Leukemia Study Groups
Authors: Sonia Jaramillo Segura, Maxi Wass, Judith Schaffrath, Kathrin Rieger, Axel Nogai, Mathias Haenel, Regina Herbst, Friedrich Stoelzel, Christoph Röllig, Edgar Jost, Richard F. Schlenk, Richard Noppeney, Christian H. Brandts, Utz Krug, Katharina S. Goetze, Sebastian Buske, Axel Florschütz, Jörg Schubert, Bernhard Opitz, Martin Mohren, Eva Eßeling, Stephan von Witzendorff, Marion Subklewe, Martin Kaufmann, Norbert Frickhofen, Christian W Scholz, Kerstin Schäfer-Eckart, Volker Kunzmann, Martin Schmidt-Hieber, Herbert G. Sayer, Andreas Rank, Philipp Hemmati, Frank Schueler, Simone Kowoll, Marina Scheller, Jörg Steighardt, Bayram Edemir, Lutz Peter Mueller, Irit Gliko-Kabir, Beatrice Ludwig-Kraus, Sabine Edemir, Ella Sorani, Mascha Binder, Abi Vainstein, Shaul Kadosh, Cora Gromann, Andreas Wienke, Claudia D. Baldus, Uwe Platzbecker, Hubert Serve, Martin Bornhaeuser, Christian Junghanss, Carsten Mueller-Tidow
Journal: Blood (2022)
Application of a Validated Composite Comorbidity Score Measuring Both Fitness and Cytogenetic Risk to Assess Outcomes in 1L AML Patients Who Received Venetoclax Plus Azacitidine in Viale-A
Authors: Adriano Venditti, Jing-Zhou Hou, Pierre Fenaux, Brian A. Jonas, Radovan Vrhovac, Pau Montesinos, Jacqueline S. Garcia, David Rizzieri, Michael J. Thirman, Melissa Montez, Yingyi Liu, John Katsetos, Jalaja Potluri, Catherine Miller, Vinod A. Pullarkat
Journal: Blood (2022)